Frontiers | Imaging-Based Methodologies for Evaluating Drugs in Clinical Trials

Imaging-Based Methodologies for Evaluating Drugs in Clinical Trials

1,676
Total downloads
5,797
Total views and downloads

Articles

CASE REPORT

Published on 19 Mar 2024

Case report: Incidental MALT lymphoma of the left adrenal gland mimicking a metastatic spread within durvalumab maintenance treatment in inoperable stage III non-small cell lung cancer

Lukas Käsmann
Esra Degerli
Karim El-Marouk
Farkhad Manapov

Case report: Incidental MALT lymphoma of the left adrenal gland mimicking a metastatic spread within durvalumab maintenance treatment in inoperable stage III non-small cell lung cancer

doi 10.3389/fonc.2024.1226422

830 views

ORIGINAL RESEARCH

Published on 04 Oct 2023

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

Hubert Beaumont
Antoine Iannessi

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

doi 10.3389/fonc.2023.1239570

1,362 views

ORIGINAL RESEARCH

Published on 29 Sep 2020

Evaluating the Treatment Efficacy of Nano-Drug in a Lung Cancer Model Using Advanced Functional Magnetic Resonance Imaging

Cuiqing Huang
Jianye Liang
Mengjie Ma
Qingqing Cheng
Xi Xu
Dong Zhang
Changzheng Shi
Ning Shang
Zeyu Xiao
Liangping Luo

Evaluating the Treatment Efficacy of Nano-Drug in a Lung Cancer Model Using Advanced Functional Magnetic Resonance Imaging

doi 10.3389/fonc.2020.563932

1,925 views
8 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Cancer Imaging and Image-directed Interventions

Impact

5,797Topic views
3,570Article views
1,676Article downloads